Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 2
2014 3
2015 8
2016 6
2017 2
2018 3
2019 2
2020 3
2021 4
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.
Davis SE, Ferris MJ, Ananthan S, Augelli-Szafran CE, Zhu J. Davis SE, et al. J Pharmacol Exp Ther. 2023 Feb;384(2):306-314. doi: 10.1124/jpet.122.001291. Epub 2022 Dec 1. J Pharmacol Exp Ther. 2023. PMID: 36456195 Free PMC article.
SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice.
Zhu J, Quizon PM, Wang Y, Adeniran CA, Strauss MJ, Jiménez-Torres AC, Patel P, Cirino TJ, Eans SO, Hammond HR, Deliscar LS, O'Hara P, Saini SK, Ofori E, Vekariya RH, Zhang S, Moukha-Chafiq O, Nguyen TH, Ananthan S, Augelli-Szafran CE, Zhan CG, McLaughlin JP. Zhu J, et al. Neuropharmacology. 2022 Dec 1;220:109239. doi: 10.1016/j.neuropharm.2022.109239. Epub 2022 Sep 17. Neuropharmacology. 2022. PMID: 36126727
Substance abuse and neurotransmission.
Davis S, Zhu J. Davis S, et al. Adv Pharmacol. 2022;93:403-441. doi: 10.1016/bs.apha.2021.10.007. Epub 2022 Jan 17. Adv Pharmacol. 2022. PMID: 35341573 Free PMC article.
Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat1-86) Protein Alters Nociceptive Processing that is Sensitive to Anti-Oxidant and Anti-Inflammatory Interventions.
Cirino TJ, Alleyne AR, Duarte V, Figueroa A, Simons CA, Anceaume EM, Kendrick J, Wallman O, Eans SO, Stacy HM, Medina JM, McLaughlin JP. Cirino TJ, et al. J Neuroimmune Pharmacol. 2022 Jun;17(1-2):152-164. doi: 10.1007/s11481-021-09985-4. Epub 2021 Feb 22. J Neuroimmune Pharmacol. 2022. PMID: 33619645 Free PMC article.
34 results